Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brantly, M.
Right arrow Articles by Gahl, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brantly, M.
Right arrow Articles by Gahl, W. A.
(Chest. 2000;117:129-136.)
© 2000 American College of Chest Physicians

Pulmonary Function and High-Resolution CT Findings in Patients With an Inherited Form of Pulmonary Fibrosis, Hermansky-Pudlak Syndrome, Due to Mutations in HPS-1*

Mark Brantly, MD; Nilo A. Avila, MD; Vorasuk Shotelersuk, MD; Cynthia Lucero, BA; Marjan Huizing, PhD and William A. Gahl, MD, PhD

* From the Clinical Studies Section, Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute (Dr. Brantly), the Warren G. Magnuson Clinical Center, Diagnostic Radiology Department (Dr. Avila), and the Section on Human Biochemical Genetics, Heritable Disorders Branch (Drs. Shotelersuk, Huizing, and Gahl, and Ms. Lucero), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.

Correspondence to: William A. Gahl, MD, PhD, 10 Center Dr, MSC 1830, Building 10, Room 9S-241, NICHD, NIH, Bethesda, MD 20892-1830; e-mail: bgahl{at}helix.nih.gov

Objective: To describe and correlate pulmonary function and high-resolution CT (HRCT) scan scores in individuals with a high risk for development of pulmonary fibrosis, ie, Hermansky-Pudlak syndrome (HPS) patients with mutations in the HPS-1 gene.

Design: Cross-sectional analysis of consecutive, eligible patients.

Patients: Thirty-eight HPS inpatients at the National Institutes of Health Clinical Center with HPS-1 mutations.

Results: Thirty-seven patients were Puerto Rican and exhibited the typical 16-base pair (bp) duplication in exon 15 of HPS-1. One non-Puerto Rican was homozygous for a different mutation (intervening sequence 17 -2 A->C) previously reported in the HPS-1 gene; he died at age 35 of pulmonary insufficiency. For the 23 patients who had pulmonary symptoms, the mean age of onset was 35 years. For all 38 patients (mean age, 37 ± 2 years), the mean FVC was 71% of predicted; the mean FEV1, 76%; mean total lung capacity (TLC), 72%; mean vital capacity (VC), 68%; and mean diffusing capacity of the lung for carbon monoxide (DLCO), 72%. When patients were grouped according to the extent of their reduction in FVC, the other four pulmonary function parameters followed the FVC. Seventeen patients had abnormal chest radiographs, and 31 (82%) had abnormal HRCT scans of the chest, for which a scoring system of 0 (normal) to 3 (severe fibrosis) is presented. The mean ± SEM HRCT score for 38 patients was 1.30 ± 0.17. HRCT scores correlated inversely with FVC and DLCO.

Conclusions: Mutations in the HPS-1 gene, whether or not they involve the typical 16-bp duplication seen in Puerto Rican patients, are associated with fatal pulmonary fibrosis. In affected patients, the FVC, FEV1, TLC, VC, and DLCO fall in concert, and this functional deficit correlates with HRCT scan evidence of progression of interstitial lung disease.

Key Words: albinism • CT scans • pulmonary fibrosis • pulmonary function tests




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS, January 1, 2006; 3(4): 315 - 321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. H. Guttentag, A. Akhtar, J.-Q. Tao, E. Atochina, M. E. Rusiniak, R. T. Swank, and S. R. Bates
Defective Surfactant Secretion in a Mouse Model of Hermansky-Pudlak Syndrome
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. K. Poddar, S. Coley, and S. Pavord
Hermansky-Pudlak syndrome in a pregnant patient
Br. J. Anaesth., November 1, 2004; 93(5): 740 - 742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
N. A. Avila, M. Brantly, A. Premkumar, M. Huizing, A. Dwyer, and W. A. Gahl
Hermansky-Pudlak Syndrome: Radiography and CT of the Chest Compared with Pulmonary Function Tests and Genetic Studies
Am. J. Roentgenol., October 1, 2002; 179(4): 887 - 892.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Gwynn, S. L. Ciciotte, S. J. Hunter, L. L. Washburn, R. S. Smith, S. G. Andersen, R. T. Swank, E. C. Dell'Angelica, J. S. Bonifacino, E. M. Eicher, et al.
Defects in the cappuccino (cno) gene on mouse chromosome 5 and human 4p cause Hermansky-Pudlak syndrome by an AP-3-independent mechanism
Blood, December 15, 2000; 96(13): 4227 - 4235.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.